Last reviewed · How we verify
Levobupivicaine
At a glance
| Generic name | Levobupivicaine |
|---|---|
| Sponsor | Ashford and St. Peter's Hospitals NHS Trust |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Does Saline Injection Around Phrenic Nerve Reduce Incidence of Diaphragmatic Paresis Following Interscalene Block? (PHASE4)
- Efficacy of the Erector Spinae Plane Block in Posterior Thoraco- Lumbar Spinal Decompression Surgery (NA)
- Efficacy of SAP Block Versus ESP Block in VATS Surgery (NA)
- Local Anaesthetic and Steroid in the Ureter (NA)
- Single-shot Pectoral Plane(PECs) Block Versus Continuous Local Anaesthetic Infusion Analgesia or Both PECS Block and Local Anaesthetic Infusion After Breast Surgery: A Prospective Randomised, Double-blind Trial (PHASE4)
- A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery (NA)
- Local Anaesthetic Infusion For Laparoscopic Hysterectomy (PHASE4)
- Intrathecal Diamorphine Versus Femoral Nerve Block in Primary Total Knee Arthroplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levobupivicaine CI brief — competitive landscape report
- Levobupivicaine updates RSS · CI watch RSS
- Ashford and St. Peter's Hospitals NHS Trust portfolio CI